About Nextrans
Nextrans is a venture capital firm founded in 2012. It is primarily based out of Seoul, South Korea. As of May 2024, Nextrans has invested in 54 companies. It primarily invests in Seed round in Vietnam based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Consumer and Life Sciences. Most recently it participated in the $***** Series B round of MedInTech Overall, Nextrans portfolio has seen 3 IPOs and 3 acquisitions including key companies like Base, OrphAI Therapeutics and Hyperfine. A lot of funds co-invest with Nextrans, with names like BonAngels Venture Partners sharing a substantial percentage of its portfolio. Nextrans has team of 5 people including 5 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Conventional Debt & 2 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Nextrans' List of Top Investments
Nextrans has a portfolio of 54 companies. Their most notable investments are in Base and Ecomobi.Their portfolio spans across South Korea, United States, Vietnam and 1 more locations. They have invested in Enterprise Applications, Consumer, Life Sciences and 22 other sectors, across stages such as Seed, Conventional Debt and 2 more. Here is the list of top investments by Nextrans:
1. Bioz
Developer of AI search engine for scientific experimentation. This platform provides researchers with scientific experimentation data, insights, and recommendations for products, equipment, and assays that help in drug discovery and finding cures for diseases.
Key facts about Bioz
- Founded Year: 2013
- Location: Los Altos (United States)
- Stage: Series A
- Total Funding till date: $17.5M
- Employee Count: 57 as on May 31, 2026
- Investors: StartX, SV Latam Capital and 13 Others
- Latest Funding Round: Grant (prize money), Apr 15, 2020, $*****
- Highlight: Editors' Pick

2. Ringle
Online platform providing English language learning solutions. The platform offers its solutions for both students as well as tutors. The platform enables students to learn English from tutors whereas tutors to register for teaching English.
Key facts about Ringle
- Founded Year: 2015
- Location: Seoul (South Korea)
- Stage: Series A
- Total Funding till date: $26.9M
- Employee Count: 889 as on May 31, 2026
- Investors: Must Asset Management, Nextrans and 5 Others
- Latest Funding Round: Series A, Mar 21, 2022, $*****
- Highlight: Editors' Pick
3. IGAWorks
Igaworks provides demand side advertising platform and audience targeting platform capable of implementing the advertisement required for each application life cycle. Started as an In-game advertisement company later shifted its focus on mobile ad tracking and app analytics platform. In addition, the TF2 platform also allows sending targeted ads to Facebook users based on the analytics performed on Facebook data.
Key facts about IGAWorks
- Founded Year: 2006
- Location: Seoul (South Korea)
- Stage: Series C
- Total Funding till date: $10.9M
- Employee Count: 124 as on May 31, 2026
- Investors: SBVA, Groom Investment and 18 Others
- Latest Funding Round: Series C, Nov 10, 2015, $*****
- Highlight: Editors' Pick
4. ImpriMed
Provider of precision medicines for veterinary cancer. The company offers different drug combinations suited for a certain cancer pet patient. The company biopsies the live cancer cells for drug responses before treatment. Based on these responses, the company uses its data-driven technology to help veterinary oncologists to fix a personalized medicinal regime for an individual.
Key facts about ImpriMed
- Founded Year: 2017
- Location: Palo Alto (United States)
- Stage: Series A
- Total Funding till date: $34.9M
- Employee Count: 44 as on May 31, 2026
- Investors: SK Telecom, StartX and 26 Others
- Latest Funding Round: Series A, Nov 06, 2023, $*****
- Highlight: Editors' Pick
Developer of digital information storage system. The company is developing a DNA-based platform for massive digital data storage and computation and it has potential to generate 160 zettabytes of data.
Key facts about Catalog Technologies
- Founded Year: 2016
- Location: San Francisco (United States)
- Stage: Series B
- Total Funding till date: $54.2M
- Employee Count: 15 as on Mar 31, 2026
- Investors: AME Cloud Ventures, Industry Ventures and 28 Others
- Latest Funding Round: Series B, Sep 30, 2021, $*****
- Highlight: Editors' Pick
Nextrans' Year-on-Year Investment Trends
Nextrans has invested in 54 companies over the last 8 years, with an average of 0 new investment annually in the last 5 years. Its most recent first time investment was in MedInTech.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 2 | 0 | 2 |
2023 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 |
2020 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2018 | 2 | 0 | 2 |
Nextrans' Investments by Stage
Nextrans has made 4 investments in Seed stage with an average round size of $1.18M, 1 investment in Conventional Debt stage with an average round size of $4.5M, 1 investment in Series A stage and 1 investment in Series B stage with an average round size of $14.6M.Stage of entry | No. of Investments |
|---|---|
Seed | 4 |
Conventional Debt | 1 |
Series A | 1 |
Series B | 1 |
Note: We have considered here, only first round of investments
Nextrans' Investments by Sector
Nextrans has a diverse portfolio, with companies operating in the Enterprise Applications, Consumer, HealthTech, Retail and Business Services. Notably, it has invested in 48 Tech companies, 30 Enterprise (B2B) companies, 23 Consumer (B2C) companies and at least 22 companies focusing on Software.Sector | No. of Investments |
|---|---|
Enterprise Applications | 3 |
Consumer | 2 |
HealthTech | 2 |
Retail | 2 |
Business Services | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
Nextrans' Investments by Geography
Nextrans has made most investments in Vietnam (5), followed by South Korea where it has made 2 investments.Country | No. of Investments |
|---|---|
Vietnam | 5 |
South Korea | 2 |
Note: We have considered here, only first round of investments
Nextrans' recent investments
Nextrans has not made any investment in 2026 so far.Here are the most recent investments by Nextrans:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 13, 2024 | South Korea | Series B | 8272 | [+7] | |
Mar 26, 2024 | South Korea | Seed | 9190 | [+1] | |
Apr 01, 2020 | Vietnam | Seed | 3166 | [+2] | |
Jul 01, 2019 | Vietnam | Series A | 4860 | - | |
May 22, 2019 | Vietnam | Conventional Debt | 7287 | [+5] |
IPOs and Publicly Listed companies in Nextrans' Portfolio
3 of Nextrans' portfolio companies have become public. ROKIT Healthcare got listed on the Korea Exchange (KRX), in May 2025 at marketcap of $76.4M and Hyperfine got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are Nextrans' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 12, 2025 | - | - | 5592 | |
Jan 27, 2021 | - | - | 4325 | |
- | Apr 01, 2020 | Seed | 9978 |
Acquired companies in Nextrans' Portfolio
3 companies from Nextrans' portfolio have been acquired. The most recent acquisition was OrphAI Therapeutics in May 2026 by Quince Therapeutics for $*****.Here are Nextrans' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 18, 2026 | - | - | 8364 | |
Apr 13, 2023 | - | - | 1720 | |
May 04, 2021 | Jul 01, 2019 | Series A | 3734 |
Team profile of Nextrans
Nextrans has a team of 5 members including 5 Partners located in South Korea. Nextrans' team does not sit on the board of any company as of now.Here is a list of all team members in Nextrans:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | South Korea | - | - | |
Partner | South Korea | - | - | |
Partner | - | - | - | |
Partner | South Korea | - | - | |
Partner | Seoul | - | - |
Co-investors of Nextrans
Over the past 8 years, 34 investors have co-invested in Nextrans's portfolio companies. This includes funds and angels.
- Invested before Nextrans: ESP Capital, Alpha JWC Ventures and 11 others have invested in rounds before Nextrans. There are 2 companies where ESP Capital has invested before Nextrans and 1 company where Alpha JWC Ventures has invested before Nextrans.
- Top Co-investors of Nextrans: 16 investors entered a company along with Nextrans. These include investors like BonAngels Venture Partners (3 companies).
- Invested after Nextrans: A total of 5 investors have invested in Nextrans's portfolio after their investments. Top Investors include CyberAgent (1 company), VinaCapital (1 company) and NAVER (1 company).
Recent News related to Nextrans
•
Xeno Holdings Signs Strategic Partnership Agreement With NextransGlobeNewswire•Feb 07, 2022•Xeno Holdings, Nextrans
•
Huami Corp Invests $5 Million In Hyperfine Research D RoundMedical Device News•Feb 10, 2021•Huami, Hyperfine, Colle Capital, Google Ventures and 1 other
•
Vietnam’s health-tech startup eDoctor raises funding from Japanese, S Korean VCsDeal Street Asia•Apr 01, 2020•EDoctor, CyberAgent Capital, Genesia Ventures, BonAngels Venture Partners and 2 others
•
VinaCapital Ventures leads investment in Vietnamese social commerce platform EcomobiKrASIA•Sep 04, 2019•VinaCapital, Ecomobi, NAVER, Line Ventures and 4 others
•
Vietnam discount startup banks $1m from CyberAgent and Bon AngelsTech in Asia•Jan 22, 2019•Jamja, ESP Capital, KB Investment, BonAngels Venture Partners and 3 others
_1557117771326.png?format=webp&height=120&width=120)